Molecular Characterization of Moraxella Catarrhalis From Pneumonic Children at Pediatric Assiut University Hospital

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1+
SponsorAssiut University

About this trial

moraxella catarrhalis is responsible for respiratory tract infection in children and adults with streptococcus pneumonia and haemophilus influenza.Moraxella catarrhalis is gram negative diplococci, non-motile and non spore bearing bacteria. Until, 1995 it was considered as a non pathogenic respiratory tract flora.This bacteria is an important pathogen and a common cause of both upper and lower respiratory tract infections, pneumonia, sinusitis and conjunctivitis in infants, children and in elderly patients. In adults, M. catarrhalis also causes chronic obstructive pulmonary disease (COPD) and pneumonia. However, it is associated with a number of respiratory infections affecting both children and adults, including laryngitis, bronchitis and pneumonia .

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

all children with bacterial pneumonia

Disqualifiers

viral pneumonia , tuberculosis and immunocompromised

Trial population

children with respiratory tract infection

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

isolation of moraxella catarrhalis

isolation of organism on muller hinton agar

Time frame
3 years

Secondary outcomes

1

detection of virulence genes of moraxella catarrhalis

detection of virulence genes by PCR

Time frame
3 years
2

detetion of antibiotic resistance

detetion of antibiotic resistance by agar disc diffusion

Time frame
3years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: